Print Page | Contact Us | Sign In | Join FSN
News & Press: COVID-19

DOH Permits Use Of Telehealth For Prescribing Controlled Substance

Thursday, March 19, 2020   (0 Comments)
Posted by: Diane Berg
Share |

DOH PERMITS USE OF TELEHEALTH FOR PRESCRIBING CONTROLLED SUBSTANCE FOR EXISTING PATIENTS DURING EMERGENCY DECLARATION

For purposes of preparing for, responding to, and mitigating any effect of COVID-19, physicians, osteopathic physicians, physician assistants, and advanced practice registered nurses licensed in Florida that have designated themselves as a controlled substance prescribing practitioner pursuant to section 456.44, may issue a renewal prescription for a controlled substance listed as Schedule II, Schedule III, or Schedule IV under chapter 893 only for an existing patient for the purpose of treating chronic nonmalignant pain without the need to conduct a physical examination of the patient.

 These practitioners may only substitute telehealth services for the physical examination. Telehealth shall have the same meaning as section 456.47(1)(a). All other minimum practice requirements and standards of care shall still apply to renewal prescriptions issued under this exception. This exception shall only apply for a period not to exceed thirty days unless extended by order of the State Surgeon General. Any statute and/or rule to the contrary is hereby suspended for a period of thirty days, unless extended.

Click here for the full DOH Declaration


FLORIDA SOCIETY OF NEPHROLOGY
1215 E. Robinson Street, Orlando, FL 32801
Phone: 813-909-0450  |  Fax: 813-949-8994